Baird Capital Portfolio Company ‘Oncology Analytics’ Rebrands as ‘OncoHealth’

Today, Baird Capital portfolio company ‘Oncology Analytics’ announced their formal rebranding to ‘OncoHealth.’ This update does not impact or change any service offerings. Instead, it aims to represent better their evolution of aligning how they serve clients and how they access digital health solutions focused on oncology.

Baird Capital invested in the company in 2020. OncoHealth is a digital health company that combines real-world data and cutting-edge analytics with a dedicated team of renowned oncology experts to deliver health plans, employers, providers, patients, and life sciences solutions for navigating the physical, mental and financial complexities of cancer. Supporting more than 7 million people in the US and Puerto Rico, OncoHealth offers digital solutions for treatment review, real-world evidence, and virtual care across all cancer types.

Learn more about the rebranding effort at www.oncohealth.us.